I've formed the assumption that the drug is safe which is why it'saccessible via SAS. it is benefiting patients but to what degree and the measuring parameters I am unsure....... we know it has a 36% reduction in proteins in urine. let's hope for a few big weeks and some excellent results. really want to be a part of this as it goes into phase 3 and develops into a commercial product.
DMX200 competition including SGLT2 Inhibitors, page-9
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
46.0¢ |
Change
-0.005(1.08%) |
Mkt cap ! $258.6M | |||
| Open | High | Low | Value | Volume |
| 47.0¢ | 49.0¢ | 45.5¢ | $1.750M | 3.717M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 45488 | 45.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 46.0¢ | 12636 | 3 |
View Market Depth
| Last trade - 15.58pm 29/07/2024 (20 minute delay) ? |
| DXB (ASX) Chart |